Who
Amit B. Shah
CFO
Company insider
Files Form 4 as: CFO, Mateon Therapeutics; Chief Financial Officer, Marina Biotech.
In numbers
- Trades disclosed
- 10
- Buys
- 4
- Sells
- 0
- Bought
- $14K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 2 Oct 2017
- Last trade
- 10 Jul 2026
- Last filed
- 14 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Jul 2026filed 14 Jul 2026 | Mateon Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,500 at $0.00 | filing |
| 10 Jul 2026filed 14 Jul 2026 | Oncotelic Therapeuticsoption or derivative | SEC FORM 4 Code A | —1,500 at $0.00 | filing |
| 22 Jun 2026filed 22 Jun 2026 | Mateon TherapeuticsBiotechnology | SEC FORM 4 Bought | $1,00020,000 at $0.05 | filing |
| 22 Jun 2026filed 22 Jun 2026 | Oncotelic Therapeutics | SEC FORM 4 Bought | $1,00020,000 at $0.05 | filing |
| 8 Jul 2021filed 16 Jul 2021 | Oncotelic Therapeutics | SEC FORM 4 Code A | —298,837 at $0.00 | filing |
| 8 Jul 2021filed 16 Jul 2021 | Oncotelic Therapeuticsoption or derivative | SEC FORM 4 Code A | —698,256 at $0.00 | filing |
| 24 Nov 2020filed 24 Nov 2020 | Mateon Therapeutics | SEC FORM 4 Bought | $1,5628,220 at $0.19 | filing |
| 23 Nov 2020filed 24 Nov 2020 | Mateon Therapeutics | SEC FORM 4 Bought | $3,81720,088 at $0.19 | filing |
| 20 Nov 2020filed 24 Nov 2020 | Mateon Therapeutics | SEC FORM 4 Bought | $6,33831,692 at $0.20 | filing |
| 2 Oct 2017filed 6 Oct 2017 | Marina Biotechoption or derivative | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.